Showing posts with label longterm followup. Show all posts
Showing posts with label longterm followup. Show all posts
Monday, September 06, 2010
abstract: Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up?
"PLD is cardiac safe for long-term treatment of metastatic solid tumors. Its maximal cumulative dose remains undefined. "
Friday, January 22, 2010
Maintenance immunotherapy in recurrent ovarian cancer: Long term follow-up of a phase II study
"Therapy consisted of low-dose subcutaneous IL-2 and oral RA, administered on intermittent schedules for up to 5 years."
Subscribe to:
Posts
(
Atom
)
